Q1 FY27 results analysis · July 28, 2026

DCM Shriram Ltd (DCMSHRIRAM) Q1 FY27 Results Analysis: PAT Jumps 42.9%, Revenue Grows 9.5%

+42.9%PAT year on year, Rs. 692.75 Cr
Cofacto ResearchPublished July 28, 20262 min readNeutral read
Quick summary

DCM Shriram Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 3,784.67 Cr (+9.50% YoY) and PAT growth of +42.90% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 28, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 3,784.67 Cr (+9.50% YoY)
PAT (Q1)Rs. 692.75 Cr (+42.90% YoY)
EBITDA margin9.62% (+19 bps YoY)
EPS (Q1)Rs. 44.42 (+447.20% YoY)
Market capRs. 16,385.87 Cr
CMPRs. 1,049.90

Quarter Snapshot

Revenue grew 9.5% YoY with normalized PAT up 42.9%, driven by the Chemicals & Vinyl segment and new ECH plant. However, margin pressures in Fertiliser and a sharp Bioseed decline are concerns, while one-time tax credits inflated reported PAT. The company maintains a strong balance sheet with improving leverage.

Key Investment Insights

Key Positives

  • Revenue grew 9.5% YoY to Rs.3,784.67 cr.
  • Normalized PAT grew 42.9% YoY to Rs.161.98 cr.
  • Chemicals & Vinyl segment revenue +25% YoY, PBIT +31.4%, margin expanded 80 bps to 17.4%.
  • Fenesta Building Systems revenue +22% YoY despite PVC cost headwind.
  • Debt/Equity improved to 0.20x from 0.21x YoY.
  • Net worth grew 18.1% YoY to Rs.8,351.96 cr.

Risk Factors

  • Bioseed segment revenue -26.1% YoY, swung from profit to loss of Rs.10.91 cr.
  • Fertiliser margin halved from 8.9% to 4.5% despite revenue growth of 10.9% YoY.
  • Power and fuel costs +10.8% YoY, outpacing revenue growth of 9.5%.
  • Fenesta margin compressed from 10.9% to 10.1% YoY due to PVC resin price surge.
  • Reported PAT inflated by one-time tax credits of Rs.474.30 cr and exceptional gains of Rs.79.42 cr.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.